CVS Health Co. (NYSE:CVS) Shares Acquired by Longfellow Investment Management Co. LLC

Longfellow Investment Management Co. LLC boosted its stake in CVS Health Co. (NYSE:CVS) by 18,352.5% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,381 shares of the pharmacy operator’s stock after acquiring an additional 7,341 shares during the period. Longfellow Investment Management Co. LLC’s holdings in CVS Health were worth $464,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health during the third quarter worth $25,000. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the 3rd quarter worth $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health in the third quarter valued at about $32,000. First Community Trust NA raised its holdings in CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in CVS Health in the third quarter valued at about $33,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Price Performance

NYSE:CVS opened at $58.85 on Monday. CVS Health Co. has a 12-month low of $52.71 and a 12-month high of $83.25. The firm has a market cap of $74.06 billion, a price-to-earnings ratio of 14.94, a price-to-earnings-growth ratio of 0.98 and a beta of 0.55. The company’s 50-day moving average is $59.21 and its two-hundred day moving average is $58.63. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.21 earnings per share. Research analysts expect that CVS Health Co. will post 5.43 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.52%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio is currently 67.51%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on CVS shares. Barclays cut their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. Mizuho reduced their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Truist Financial reaffirmed a “buy” rating and set a $67.00 price target (down from $76.00) on shares of CVS Health in a research note on Wednesday, November 20th. Royal Bank of Canada reduced their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $70.61.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.